CDER Adds Gaucher Disease to 2017 Guidance Agenda Post author:Sam Post published:April 20, 2017 Post category:Drug Industry Daily CDER updated its guidance agenda for 2017, adding an item on Gaucher Disease. Source: Drug Industry Daily You Might Also Like Pfizer CEO Predicts Trump Administration Will Eliminate Drug Rebates July 31, 2018 FDA Releases Guidance on ‘Fit-for-Purpose’ Clinical Outcome Assessments June 29, 2022 Biogen Cuts Aduhelm Cost by 50 Percent, Hoping to Secure Insurance Coverage December 20, 2021
